Description:
Starpharma is one of the world’s leading nanotechnology companies exploiting properties of compounds known as dendrimers across a range of applications including therapeutics, drug delivery and other non-pharmaceutical applications. Starpharma is a major shareholder in US-based company Dendritic Nanotechnologies ("DNT") which has been the recipient of several US Government grants to further the development and applications of dendrimer-based compounds and is part of a select group of members of the Institute for Soldier Nanotechnology in the USA.